Evidence map›Paper›PMID 28822833›Full record

ArticleClinical immunology (Orlando, Fla.)2017

Complete knockout of estrogen receptor alpha is not directly protective in murine lupus.

Jennifer L Scott, Jena R Wirth, Jackie Eudaly, Phil Ruiz, Melissa A Cunningham

Open access · greenAbstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Autoimmune Disease-Associated Hypertension.Current hypertension reports · 2019
    Review
  6. Article
  7. Article
  8. Sex bias in autoimmunity.Current opinion in rheumatology · 2019
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jennifer L ScottMedical University of South Carolina, Division of Rheumatology and Immunology, Charleston, SC 29425, USA.
Jena R WirthMedical University of South Carolina, Division of Rheumatology and Immunology, Charleston, SC 29425, USA.
Jackie EudalyMedical University of South Carolina, Division of Rheumatology and Immunology, Charleston, SC 29425, USA.
Phil RuizUniversity of Miami, School of Medicine, Department of Pathology, 1611 N.W. 12th Ave., Holtz Center, East Tower, Room 2101, Miami, FL 33136, USA.
Melissa A CunninghamMedical University of South Carolina, Division of Rheumatology and Immunology, Charleston, SC 29425, USA. Electronic address: cunnima@musc.edu.
Medical University of South Carolina · USUniversity of Miami · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
South Carolina Clinical & Translational Research Institute (SCTR)KL2TR001452 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MCRAE-CLARK, AIMEE L · 2015 to 2024
$5.9M
Molecular mechanisms of estrogen receptor alpha modulating the inflammatory response in systematic lupus erythematosusK08AR068471 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CUNNINGHAM, MELISSA A · 2016 to 2020
$861k
South Carolina Clinical & Translational Research Institute (SCTR)KL2TR000060 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$807k
Role of Estrogen Receptors in Lupus-Modulators of the Inflammatory ResponseI01BX000470 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI GILKESON, GARY S · 2009 to 2013
–
BLRD VA I01 BX000470NCATS NIH HHS KL2 TR000060NCATS NIH HHS KL2 TR001452NCATS NIH HHS UL1 TR000062NCI NIH HHS P30 CA138313NIAMS NIH HHS K08 AR068471
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a chronic and potentially severe autoimmune disease that disproportionately affects women. Despite a known role for hormonal factors impacting autoimmunity and disease pathogenesis, the specific mechanisms of action remain poorly understood. Our laboratory previously backcrossed "estrogen receptor alpha knockout (ERαKO)" mice onto the NZM2410 lupus prone background to generate NZM/ERαKO mice. This original ERαKO mouse, developed in the mid-1990s and utilized in hundreds of published studies, is not in fact ERα null. They express an N-terminally truncated ERα, and are considered a functional KO. They have physiologic deficiencies including infertility due to disruption of a critical activation domain (AF-1) at the N terminus of ERα, required for most classic estrogen (E2) actions. We demonstrated that female NZM/ERαKO mice had significantly less renal disease and significantly prolonged survival compared to WT littermates despite similar serum levels of autoantibodies and glomerular immune complex deposition. Herein, we present results of experiments using a lupus prone true ERα-/- mice (deletional KO mice on the NZM2410 background), surprisingly finding that these animals were not protected if they were ovariectomized, suggesting that another hormonal component confers protection, possibly testosterone, rather than the absence of the full-length ERα.

Indexed as

AnimalsAntibodies, AntinuclearAntibody FormationAutoantibodiesDNAEstradiolEstrogen Receptor alphaFemaleGenetic Predisposition to DiseaseKidneyLupus Erythematosus, SystemicMiceMice, KnockoutOvariectomyTestosteroneAntibodies, AntinuclearAutoantibodiesDNAEstradiolEstrogen Receptor alphaTestosteroneAutoantibodyEstrogenEstrogen receptor alphaLupusTestosterone

Identifiers

PMID28822833
PMCPMC6261466
OpenAlexW2750256134

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.